1
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed With Plasmodium Falciparum
Condition(s):MalariaLast Updated:February 23, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):MalariaLast Updated:February 23, 2024Not yet recruiting
Condition(s):Post-COVID-19Last Updated:February 23, 2024Completed
Condition(s):COVID-19Last Updated:September 15, 2023Withdrawn
Condition(s):COVID-19Last Updated:February 23, 2024Suspended
Condition(s):Covid19Last Updated:September 15, 2023Completed
Condition(s):COVID-19Last Updated:September 15, 2023Completed
Condition(s):Malaria (Plasmodium Falciparum)Last Updated:September 21, 2023Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.